Ocera Therapeutics Inc (OCRX) Financial Statements (2024 and earlier)

Company Profile

Business Address 555 TWIN DOLPHIN DRIVE
REDWOOD CITY, CA 94065
State of Incorp. CA
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2017
MRQ
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 28,36043,33647,23945,70015,319
Cash and cash equivalents 24,61135,92110,12715,53315,319
Short-term investments 3,7497,41537,11230,167 
Receivables  596293152
Disposal group, including discontinued operation    3,029 
Prepaid expense and other current assets369
Other undisclosed current assets 584627970470746
Total current assets: 28,94444,02248,27149,29216,586
Noncurrent Assets
Property, plant and equipment 64946159942
Long-term investments and receivables   3,9281,513 
Long-term investments   3,9281,513 
Intangible assets, net (including goodwill) 595595766930
Goodwill 595595595595 
Intangible assets, net (excluding goodwill)   171335 
Deposits noncurrent assets 36262626 
Total noncurrent assets: 6957154,7812,528942
TOTAL ASSETS: 29,63944,73753,05251,82017,528
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 2,8393,1331,9661,9022,518
Interest and dividends payable 94    
Employee-related liabilities 1,124993   
Accounts payable   9411,2821,678
Accrued liabilities   1,9661,902840
Other undisclosed accounts payable and accrued liabilities 1,6212,140(941)(1,282) 
Debt 9,703    
Disposal group, including discontinued operation    3,503 
Deferred revenue and credits     599
Other undisclosed current liabilities 1,2157019411,282 
Total current liabilities: 13,7573,8342,9076,6873,117
Noncurrent Liabilities
Long-term debt and lease obligation  9,508 138
Long-term debt, excluding current maturities  9,508 138
Liabilities, other than long-term debt 1451   
Deferred revenue and credits 1451   
Other undisclosed noncurrent liabilities     99
Total noncurrent liabilities: 1459,509 1137
Total liabilities: 13,90213,3432,9076,6883,254
Equity
Equity, attributable to parent 15,73731,39450,14545,13214,274
Additional paid in capital 174,065162,832155,083126,615144,413
Accumulated other comprehensive income (loss)  (5)(27)3(665)
Accumulated deficit (158,328)(131,433)(104,911)(81,486)(129,474)
Total equity: 15,73731,39450,14545,13214,274
TOTAL LIABILITIES AND EQUITY: 29,63944,73753,05251,82017,528

Income Statement (P&L) ($ in thousands)

9/30/2017
TTM
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues 609133341858,447
Revenue, net  133341858,447
Gross profit: 609133341858,447
Operating expenses (26,489)(26,469)(25,019)(15,414)(27,541)
Operating loss: (25,880)(26,336)(24,678)(15,329)(19,094)
Nonoperating income (expense) (1,015)(413)54(160)(1,373)
Other nonoperating expense     (1,373)
Interest and debt expense     (3,756)
Other undisclosed income from continuing operations before equity method investments, income taxes     1,379
Loss from continuing operations: (26,895)(26,749)(24,624)(15,489)(22,844)
Loss before gain (loss) on sale of properties: (26,895)(26,749)(24,624)(15,489)(22,844)
Net loss: (26,895)(26,749)(24,624)(15,489)(22,844)
Other undisclosed net income (loss) attributable to parent  2271,199(2,025) 
Net loss available to common stockholders, diluted: (26,895)(26,522)(23,425)(17,514)(22,844)

Comprehensive Income ($ in thousands)

9/30/2017
TTM
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss: (26,895)(26,749)(24,624)(15,489)(22,844)
Other undisclosed comprehensive income (loss) 52491,169(2,022)18
Comprehensive loss, net of tax, attributable to parent: (26,890)(26,500)(23,455)(17,511)(22,826)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: